Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wesley Y Yu

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Annals of Surgical Oncology|July 12, 2025
Correction: Enhanced Risk Stratification for Sentinel Lymph Node Biopsy in Head and Neck Melanoma Using the Merlin Assay (CP-GEP)Ani Pazhava, Wesley Y Yu, Frank Z Jing, et al.
Journal of the American Academy of Dermatology|October 15, 2025
CP-GEP identifies high-risk T1a melanoma patients beyond established adverse featuresWesley Y Yu, Ani Pazhava, Marie B Weitemeyer, et al.
Journal of the American Academy of Dermatology|January 19, 2025
Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excisionJaclyn N Roland-McGowan, Steven Caleb Freeman, Wenelia Baghoomian, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 30, 2024
Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi StudyKristen K Curtis, Nathan J Fakult, Jennifer L Strunck, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Annals of Surgical Oncology|July 12, 2025
Correction: Enhanced Risk Stratification for Sentinel Lymph Node Biopsy in Head and Neck Melanoma Using the Merlin Assay (CP-GEP)Ani Pazhava, Wesley Y Yu, Frank Z Jing, et al.
Journal of the American Academy of Dermatology|October 15, 2025
CP-GEP identifies high-risk T1a melanoma patients beyond established adverse featuresWesley Y Yu, Ani Pazhava, Marie B Weitemeyer, et al.
Journal of the American Academy of Dermatology|January 19, 2025
Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excisionJaclyn N Roland-McGowan, Steven Caleb Freeman, Wenelia Baghoomian, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 30, 2024
Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi StudyKristen K Curtis, Nathan J Fakult, Jennifer L Strunck, et al.
Pageof 4